No One Should Die of Cancer 

 

Cancer is the leading cause of death for adults in the United States. At Tocagen, we believe that no one should die of cancer. We believe cancer should be a manageable disease, and that long term remission or even elimination of disease is possible. We are dedicated to finding new treatments to bring new hope to people with advanced cancer. Tocagen is initially focusing on treatments for brain cancer patients for whom no adequate treatment currently exists. We believe the founding technology of the Company will allow us to develop drugs which will be more effective, with fewer side effects, than many current conventional cancer treatments. Read more about Tocagen’s clinical trial in recurrent High Grade Glioma.

 

Welcome

Thank you for visiting the Tocagen website and for your interest in learning more about our fight against cancer. This website contains information about our company, technology, products and clinical programs. At Tocagen, we are dedicated to fulfilling our Mission and bringing new hope to patients with advanced cancer.   - Harry Gruber, MD, Chief Executive Officer, Tocagen Inc.

Resources    Tocagen’s Clinical Trial Listing on www.clinicaltrials.gov     Learn About Tocagen's Product Candidates    View Tocagen's Presentations    See Tocagen's available jobs.   Like us on facebook.

News     Tocagen Announces First-in-Human Clinical Trial in Brain Cancer     ABTA Awards Clinical Research Grant to Tocagen      NBTS Awards Research Grant to Tocagen     Accelerate Brain Cancer Cure (ABC2) Awards Grant     Stay informed of Tocagen's progress and breaking news.     Subscribe to Tocagen's email newsletter.

Privacy Policy | Terms of Use | www.tocagen.com   3030 Bunker Hill St. Suite 230  San Diego, CA 92109          Main (858) 412-8400  Fax (858) 412-8499  © Copyright 2012 Tocagen Inc.